Pharmacology, Toxicology and Pharmaceutical Science
Depressive Disorder
45%
Placebo
45%
Bipolar Disorder
37%
Inflammatory Bowel Disease
25%
Treatment Resistant Depression
25%
Prevalence
25%
Randomized Clinical Trial
25%
Placebo-Controlled Study
25%
Irritable Colon
25%
Mood Disorder
25%
Antidepressant
25%
Tolerability
25%
N Methyl Dextro Aspartic Acid
16%
Glutamate Decarboxylase
16%
Symptomatology
16%
Combination Therapy
12%
Major Depression
12%
Monotherapy
12%
Bipolar Depression
12%
Brain Derived Neurotrophic Factor
8%
Gastrointestinal Disease
8%
Intestine Flora
8%
Controlled Clinical Trial
8%
C Reactive Protein
8%
Neuroscience
Placebo
83%
Meta-Analysis
75%
Major Depressive Disorder
50%
Bipolar Disorder
50%
Depressive Disorder
37%
Mental Disorder
33%
Antidepressant
29%
Treatment-Resistant Depression
25%
Drug Therapy
25%
N-Methyl-D-Aspartic Acid
16%
Tamsulosin
12%
Anti-Inflammatory
8%
Butyrate
8%
Bipolar Depression
8%
Mood Disorder
8%
C-Reactive Protein
8%
Brain-Derived Neurotrophic Factor
8%
Butyric Acid
8%
Psychology
Meta-Analysis
100%
Bipolar Disorder
91%
Systematic Review
58%
Mental Health
37%
Psychoeducation
25%
World Health Organization
25%
Depressive Disorder
25%
Irritable Bowel Syndrome
25%
Standardized Mean Difference
16%
Schizophrenia
16%
Self-Management
12%
Mental Health Program
12%
Psychological Treatment
8%
Placebo Effect
8%
Psychological Effect
8%
Mood Disorder
8%
Healthcare Professional
6%
Information Technology
6%